{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:28:35Z","timestamp":1761092915484,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.urolonc.2006.07.021","type":"journal-article","created":{"date-parts":[[2007,5,6]],"date-time":"2007-05-06T17:41:57Z","timestamp":1178473317000},"page":"221-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Bacillus Calmette-Gu\u00e9rin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway"],"prefix":"10.1016","volume":"25","author":[{"given":"Guangjian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanghong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"See","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2006.07.021_bib1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","article-title":"Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer","volume":"170","author":"Bohle","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2006.07.021_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","article-title":"Role of urothelial cells in BCG immunotherapy for superficial bladder cancer","volume":"91","author":"Bevers","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2006.07.021_bib3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/01.ju.0000067623.43110.4c","article-title":"Bacillus Calmette-Guerin initiates intracellular signaling in a transitional carcinoma cell line by cross-linking alpha 5 beta 1 integrin","volume":"170","author":"Chen","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2006.07.021_bib4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0022-5347(05)64745-3","article-title":"Interleukin-6 production by human bladder tumor cell lines is up-regulated by bacillus Calmette-Guerin through nuclear factor-kappaB and Ap-1 via an immediate early pathway","volume":"168","author":"Chen","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2006.07.021_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01517219","article-title":"Antiproliferative effects of bacillus Calmette-Guerin and interferon alpha 2b on human bladder cancer cells in vitro","volume":"41","author":"Pryor","year":"1995","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.urolonc.2006.07.021_bib6","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0022-5347(05)64362-5","article-title":"Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium Bovis (bacillus Calmette-Guerin)","volume":"168","author":"Seow","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2006.07.021_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2490-5-8","article-title":"BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking","volume":"5","author":"Chen","year":"2005","journal-title":"BMC Urol"},{"key":"10.1016\/j.urolonc.2006.07.021_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","article-title":"WAF1, a potential mediator of p53 tumor suppression","volume":"75","author":"el-Deiry","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2006.07.021_bib9","first-page":"460","article-title":"Use of a chemically modified T7 DNA polymerase for manual and automated sequencing of supercoiled DNA","volume":"6","author":"Toneguzzo","year":"1988","journal-title":"Biotechniques"},{"key":"10.1016\/j.urolonc.2006.07.021_bib10","first-page":"569","article-title":"p53 mutations in bladder carcinoma cell lines","volume":"6","author":"Cooper","year":"1994","journal-title":"Oncol Res"},{"key":"10.1016\/j.urolonc.2006.07.021_bib11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/00006123-199705000-00025","article-title":"Current concepts in neuro-oncology: The cell cycle\u2013A review","volume":"40","author":"Dirks","year":"1997","journal-title":"Neurosurgery"},{"key":"10.1016\/j.urolonc.2006.07.021_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00000372-199806000-00015","article-title":"A review of tumor suppressor genes in cutaneous neoplasms with emphasis on cell cycle regulators","volume":"20","author":"Smith","year":"1998","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.urolonc.2006.07.021_bib13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/366701a0","article-title":"p21 is a universal inhibitor of cyclin kinases","volume":"366","author":"Xiong","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2006.07.021_bib14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2006.07.021_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/excr.1998.4319","article-title":"Transcriptional regulation of the p21((WAF1\/CIP1)) gene","volume":"246","author":"Gartel","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.urolonc.2006.07.021_bib16","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/90.14.1072","article-title":"Effect of p21WAF1\/CIP1 expression on tumor progression in bladder cancer","volume":"90","author":"Stein","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2006.07.021_bib17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000050635","article-title":"Prognostic value of p53, p21\/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas","volume":"22","author":"Wolf","year":"2001","journal-title":"Tumour Biol"},{"key":"10.1016\/j.urolonc.2006.07.021_bib18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2003.11.011","article-title":"Prognostic factors in stage T1 grade 3 bladder cancer survival: The role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1)","volume":"45","author":"Lopez-Beltran","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2006.07.021_bib19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1464-410x.2001.02268.x","article-title":"p53, p21 and mdm2 expression vs. the response to radiotherapy in transitional cell carcinoma of the bladder","volume":"88","author":"Rotterud","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2006.07.021_bib20","first-page":"1295","article-title":"Correlation of clinical outcome with p53 and p21 status in patients with advanced transitional-cell carcinoma treated with paclitaxel and carboplatin","volume":"22","author":"Flamm","year":"2002","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2006.07.021_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00005392-199907000-00072","article-title":"Intravesical bacillus calmette-guerin (BCG) as inducer of tumor-suppressing proteins p53 and p21 Waf1-Cip1 during treatment of superficial bladder cancer","volume":"162","author":"Fontana","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2006.07.021_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005392-199907000-00017","article-title":"p53 mutations in bladder tumors inactivate the transactivation of the p21 and Bax genes, and have a predictive value for the clinical outcome after bacillus Calmette-Guerin therapy","volume":"162","author":"Pfister","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2006.07.021_bib23","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0022-5347(01)61770-1","article-title":"Correlation and prognostic significance of p53, p21WAF1\/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy","volume":"161","author":"Zlotta","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2006.07.021_bib24","first-page":"621","article-title":"WAF1\/p21 regulates proliferation, but does not mediate p53-dependent apoptosis in urothelial carcinoma cell lines","volume":"12","author":"Makri","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/j.urolonc.2006.07.021_bib25","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0022-5347(05)67877-9","article-title":"The growth inhibitory effect of p21 adenovirus on human bladder cancer cells","volume":"163","author":"Hall","year":"2000","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143906002432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143906002432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:53:03Z","timestamp":1761040383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143906002432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S1078143906002432"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2006.07.021","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacillus Calmette-Gu\u00e9rin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2006.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}